International Reviews of Immunology · 2001 · 10 citations · 15 references
Hepatitis C VirusHumoral ResponseViral PathogenesisImmunologyImmunotherapySpecialized PhageViral HepatitisVaccine TargetHypervariable Region 1VirologyAutoimmunityHumoral ImmunityChronic Viral InfectionVaccinationHcv PatientsAntiviral ResponseHepatitisVaccine DesignMedicine
Hepatitis C Virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma, worldwide, and the development of an effective vaccine represents a high priority goal. The Hyper Variable Region 1 (HVR1) of the second Envelope protein (E2) of HCV contains a principal neutralizing determinant, but it is highly variable among different isolates and it is involved in the escape from host immune response. Thus, to be effective, a vaccine should elicit a cross-reacting humoral response against the majority of viral variants. We show that it is possible to achieve a broadly cross-reactive immune response in rabbits by immunization with mimotopes of the HVR1. selected from a specialized phage library using HCV patients' sera. At least some of the cross-reacting anti-mimotope antibodies, elicited in rabbits, recognize discontinuous epitopes in a manner similar to those induced by the virus in infected patients.
15
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Qui‐Lim Choo, George Kuo, Amy J. Weiner et al. · Science · 1989 · 6.9K citations
The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies
Patrizia Farci, Atsushi Shimoda, Alessandra Coiana et al. · Science · 2000 · 881 citations
Amy J. Weiner, H. Mario Geysen, Cindy Christopherson et al. · Proceedings of the National Academy of Sciences · 1992 · 709 citations · Full text
Patrizia Farci, Atsushi Shimoda, Doris C. Wong et al. · Proceedings of the National Academy of Sciences · 1996 · 596 citations